AI Data Broker for Healthcare: What Is Possible in Canada
Patient trust is not for sale. Some of your other data might be.
An AI data broker for healthcare has to start with what cannot be sold, and in Canada that is most patient data. Healthcare data licensing for AI is possible in Canada, but it is much narrower than the headlines suggest. Identifiable patient information is not for sale, and even de-identified data should only move through proper legal, privacy, and ethics processes. We help clinics and health businesses sort what they could license from what they cannot, and we tell you plainly when the next step is privacy counsel, not a buyer.
You have heard health data is valuable to AI companies. You also know patient trust is not negotiable.
Maybe a vendor has asked about your records, or you have read about AI companies paying for training data. If you run a clinic, a practice group, or a health business, it is natural to wonder whether your images, notes, or clinical content have value, and whether using them that way would ever be acceptable.
The answer splits in two. Patient data is tightly governed by provincial health privacy laws, professional obligations, and research ethics, and for most private practices it is not realistically licensable. Content your organization created that contains no patient information, such as education materials, protocols, and simulation video, can be licensed much like any other business asset.
Most of this page is about knowing the difference. Where patient data is involved, our role is to help you understand the landscape and get the right counsel involved, not to broker records.
What Sells
Data in healthcare that AI buyers want
Clinical content you wrote
Patient education handouts, care pathways, protocols, and staff training written by your clinicians, with no patient information in them. Plain-language and bilingual material is especially useful for health AI that has to explain things to patients.
Simulation and training video
Procedures and skills recorded on manikins or in simulation settings with consenting staff and no patients. This kind of footage may interest developers of medical training and robotics systems, with far less privacy risk.
De-identified clinical data, only through proper process
Imaging, notes, or structured records, only where the law permits it, after formal de-identification and a documented re-identification risk assessment, with privacy counsel and often ethics review. In practice this is usually a health system decision, not a small clinic one.
Controlled access instead of handing over copies
Some institutions let developers train on de-identified data inside a controlled environment, so the data never leaves their custody. This model keeps far more control in the data holder's hands than selling a copy.
Who wants health data, and how large institutions handle it
Health AI developers need clinical data with depth and diversity. One example of how large institutions are responding: in 2023, Toronto's University Health Network became a founding member of Mayo Clinic Platform_Connect, a distributed data network where each health system keeps control of its de-identified data. That is access under controls, not a sale of patient records.
In Canada, research access to health data largely runs through governed environments. Population Data BC runs a Secure Research Environment where researchers carry out their analysis while privacy-sensitive data stays protected, and ICES, an independent not-for-profit that receives core funding from Ontario's Ministry of Health, produces health research and evidence for the health system. These routes exist for approved research, and they show the bar any other use has to meet.
For a private clinic, the realistic buyers are usually for non-patient content. For patient data, the realistic path is partnering with a research institution or health system on terms your privacy counsel approves.
Before You Sell
The legal and ethical lines in healthcare
- Which law applies depends on who you are. In BC, PIPA applies to physicians in private practice, while FIPPA applies to personal information handled in hospitals, health authorities, and ministries. Ontario has PHIPA for health information custodians, New Brunswick, Newfoundland and Labrador, and Nova Scotia have their own health information laws, and other provinces and territories have health privacy laws too.
- Research is not a back door. Ontario's PHIPA allows custodians to disclose personal health information to researchers without consent only under strict conditions, including a research plan approved by a research ethics board and a written agreement with the custodian. Licensing data to a commercial AI company is not automatically research.
- Research ethics: under Canada's Tri-Council Policy Statement (TCPS 2), using identifiable information without consent for research requires a research ethics board to be satisfied of several conditions, including that seeking consent is impossible or impracticable.
- De-identified is not anonymous. Removing names does not stop re-identification when data is combined with other sources. Ontario's Information and Privacy Commissioner updated its de-identification guidelines in October 2025, and Quebec's anonymization regulation requires a formal process and a register.
- AI training needs legal authority. Canada's privacy commissioners say organizations should know and document their legal authority, often valid and meaningful consent, for using personal information to train generative AI.
- Professional duties apply on top of privacy law. Check your regulatory college's confidentiality standards, and get advice from privacy counsel with health sector experience before any patient-derived data is discussed with a buyer.
General information, not legal advice. Have a lawyer review rights, consent, and any licensing contract.
The Canadian angle
Health privacy in Canada is a provincial patchwork, and the right answer depends on your province, whether you are a public body or a private practice, and how the data was collected. Anyone offering a single national answer is oversimplifying.
Quebec's anonymization regulation, in force since May 2024, sets out a formal framework, periodic re-identification checks, and a register of anonymized information. It is a useful model for documentation even outside Quebec.
Canada also has strong, publicly trusted research infrastructure for health data. If your goal is to see clinical data used to improve care, working with that infrastructure may serve patients better than any commercial deal. We will say so when it does.
How It Works
From archive to licensing deal
We review what you hold, estimate a realistic value, work with your lawyer on rights and consent, document the dataset, and route it to the right buyers. You pay a success fee only if a deal closes. See the full process on our AI data licensing page.
FAQ
Questions about AI data broker for healthcare
Not identifiable patient data, and not without a proper legal basis, de-identification, and usually ethics review even when it is de-identified. For most private practices the realistic answer is no. This is general information, not legal advice; speak to privacy counsel with health sector experience.
Not automatically. De-identified data can sometimes be re-identified when combined with other information, which is why regulators publish detailed de-identification guidance and Quebec requires a formal anonymization process. Any project needs a documented risk assessment approved by counsel.
Content your organization created: patient education materials, protocols, care pathways, staff training, and simulation video recorded with consenting staff and no patients. Ownership still has to be clear, and clinicians who wrote material may need to be asked.
They allow some research uses under strict conditions. Ontario's PHIPA, for example, requires an approved research plan from a research ethics board and a written agreement with the custodian. Commercial AI licensing is a different purpose, so do not assume research rules cover it.
For non-patient content, sometimes. For patient data, rarely, and only through a partnership with a research institution or health system on terms counsel approves. We will give you an honest read on the first call, including when the answer is not to proceed.
No. We do not receive or process identifiable patient information, and we do not give legal advice. For patient-derived data, our role is to explain the landscape and bring in privacy counsel; we focus our licensing work on content that contains no patient information.
Related Reading
How to Sell Your Data to AI Companies from Canada: Process, Buyers, and the Law
AI for Dentists and Healthcare Practices: A Practical Guide
What AI Companies Pay for Training Data in 2026: Every Public Price, Sourced
Other Industries
Sources: OPC, summary of privacy laws in Canada · OPC, provincial laws that may apply instead of PIPEDA · Doctors of BC, physicians privacy toolkit fact sheet · Ontario, Personal Health Information Protection Act · University of Windsor REB, PHIPA section 44 requirements · TCPS 2 (2022), Chapter 5 · BLG, the new IPC Ontario de-identification guidelines · Blakes, Quebec's anonymization regulation · OPC, principles for generative AI · UHN, global collaboration with Mayo Clinic · Population Data BC · ICES, about
Sitting on healthcare data? Find out what it is worth.
Book a free call. Tell us what you hold, and we will give you an honest read on whether it is worth licensing.